Position in SCYX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$45,677
+$45,675 QoQ
Shares Held
11,223
Ownership
0.113%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 39 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SCYX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. SCYX ranks #57 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,643,241 | $261,803,294 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
9,910,822 | $243,905,327 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
220,616 | $119,536,366 | |
| 4 | VTRS |
Viatris Inc
|
6,092,296 | $96,745,659 | |
| 5 | LNTH |
Lantheus Holdings, Inc.
|
835,494 | $92,689,703 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
2,660,810 | $92,250,281 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
545,937 | $92,012,220 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,140,065 | $72,505,400 |
All Filings in SCYX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $45,677 | 11,223 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $2 | 4 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $14,871 | 23,533 | Shares | Defined | 2026-01-29 | |
| 2025-09-30 | $40,162 | 52,159 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $42,994 | 63,696 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $65,576 | 68,885 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $102,325 | 84,567 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $22,361 | 15,008 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $30,006 | 15,003 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $4 | 3 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $6 | 3 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $7,430 | 3,259 | Shares | Sole | 2023-11-09 | |
| 2023-03-31 | $6,144 | 2,048 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $7,876 | 5,049 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $13,617 | 5,674 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $5,438 | 2,924 | Shares | Sole | 2022-08-10 | |
| 2021-12-31 | $15,103 | 2,476 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $180 | 34 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $6,182 | 840 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $624,338 | 78,632 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $509,076 | 66,546 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $14,958 | 3,392 | Shares | Sole | 2020-11-12 | |
| 2020-03-31 | $8,634 | 11,056 | Shares | Sole | 2020-05-01 | |
| No filing history on record for this holder in this stock. | ||||||